Literature DB >> 17082464

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

E R Dorsey1, R Constantinescu, J P Thompson, K M Biglan, R G Holloway, K Kieburtz, F J Marshall, B M Ravina, G Schifitto, A Siderowf, C M Tanner.   

Abstract

Based on published prevalence studies, we used two different methodologies to project the number of individuals with Parkinson disease (PD) in Western Europe's 5 most and the world's 10 most populous nations. The number of individuals with PD over age 50 in these countries was between 4.1 and 4.6 million in 2005 and will double to between 8.7 and 9.3 million by 2030.

Entities:  

Mesh:

Year:  2006        PMID: 17082464     DOI: 10.1212/01.wnl.0000247740.47667.03

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  619 in total

Review 1.  Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.

Authors:  Ying Zi; Zhongmin Yin; Weizhong Xiao; Xinwei Liu; Zhixiang Gao; Li Jiao; Lianfu Deng
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

Review 2.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 3.  Screening questionnaires for parkinsonism: a systematic review.

Authors:  Nabila Dahodwala; Andrew Siderowf; Mona Baumgarten; Aaron Abrams; Jason Karlawish
Journal:  Parkinsonism Relat Disord       Date:  2011-09-17       Impact factor: 4.891

4.  Healthcare Data Analytics for Parkinson's Disease Patients: A Study of Hospital Cost and Utilization in the United States.

Authors:  Sunanda Mukherjee; Huanmei Wu; Josette Jones
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

Review 5.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

Review 6.  Movement disorders in 2011: Translating new research findings into clinical practice.

Authors:  Christine Klein; Dimitri Krainc
Journal:  Nat Rev Neurol       Date:  2011-12-20       Impact factor: 42.937

7.  [Perioperative management and anesthesia in Parkinson's disease : interdisciplinary challenge].

Authors:  H Fink
Journal:  Anaesthesist       Date:  2012-02       Impact factor: 1.041

Review 8.  [Parkinson's disease in the elderly].

Authors:  Rüdiger Lange; Frank Erbguth
Journal:  Z Gerontol Geriatr       Date:  2017-07-19       Impact factor: 1.281

9.  Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Authors:  Lee J Martin; Samantha Semenkow; Allison Hanaford; Margaret Wong
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

Review 10.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.